Mayo clinic tests procedure to reduce esophageal cancer risk
NCT ID NCT00587314
Summary
This study is looking at how well two FDA-approved ablation procedures work for controlling Barrett's esophagus, a condition that can lead to esophageal cancer. Researchers will follow 600 patients who have received or qualify for these treatments to see if Barrett's tissue returns over time. The goal is to better understand the long-term effectiveness of these cancer-risk reduction procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT'S ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.